Share Price and Basic Stock Data
Last Updated: December 11, 2025, 10:19 pm
| PEG Ratio | 26.67 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Andrew Yule & Company Ltd operates primarily in the tea and coffee plantation sector, a niche that has seen fluctuating demand and pricing pressures over the years. As of the latest reporting, the company’s market capitalization stood at ₹1,117 Cr, with its stock trading at ₹22.8. Revenue figures have shown some volatility, with sales reported at ₹374 Cr for FY 2023, slightly declining from ₹414 Cr in FY 2022. The trailing twelve months (TTM) revenue remained flat at ₹312 Cr, indicating a stagnation that might raise eyebrows among potential investors. Quarterly sales trends reveal a pattern of ups and downs, with the most recent quarter showing a modest recovery in sales at ₹88 Cr in September 2023 after a dip to ₹59 Cr in June 2023. This inconsistency in revenue generation could be a critical factor for investors to consider, as it reflects both market conditions and operational challenges the company might be facing.
Profitability and Efficiency Metrics
Andrew Yule’s profitability metrics tell a concerning story. The company recorded a net profit of just ₹20 lakh for FY 2023, a stark contrast to previous years, where it faced significant losses. Notably, the operating profit margin (OPM) has been in negative territory, deteriorating to -49% in the latest quarter. This raises questions about operational efficiency and cost management, especially when expenses have remained relatively high, peaking at ₹112 Cr in March 2024. The interest coverage ratio (ICR) stands at 0.00x, indicating that the company is unable to cover its interest expenses with its earnings. Such a scenario can lead to increased financial strain, especially if the company does not manage to turn its profitability around. Investors should closely monitor these metrics as they provide insight into the operational health and sustainability of the business.
Balance Sheet Strength and Financial Ratios
Examining Andrew Yule’s balance sheet, the company shows a mixed picture. With total borrowings of ₹120 Cr and reserves at ₹264 Cr, the debt-to-equity ratio appears manageable at 0.31x. However, the current ratio is a concerning 0.66, suggesting potential liquidity issues, as the company may struggle to meet its short-term obligations. Furthermore, the return on equity (ROE) is reported at a modest 7.96%, which, while positive, is relatively low compared to industry standards, indicating that shareholders might not be reaping adequate returns for their investment. The asset turnover ratio of 0.42% also signals inefficiencies in utilizing assets to generate revenue. Investors should weigh these financial ratios carefully, as they highlight the company’s operational challenges and financial stability.
Shareholding Pattern and Investor Confidence
The shareholding structure of Andrew Yule reflects significant promoter confidence, with promoters holding 89.25% of the company. This high concentration could be seen as a strength, suggesting that the management is committed to the business. However, the lack of foreign institutional investment (FIIs) and minimal domestic institutional investment (DIIs) at 2.20% raises concerns about broader market confidence in the company’s prospects. The public shareholding stands at 8.55%, indicating limited retail investor participation. This could mean that the stock is relatively illiquid, which might deter some investors. The number of shareholders has increased to 47,115, suggesting a growing interest at the retail level, but the overall lack of institutional backing could be a red flag for more cautious investors.
Outlook, Risks, and Final Insight
Looking ahead, Andrew Yule faces a complex landscape. The company’s operational inefficiencies and fluctuating sales pose significant risks to its profitability. While the strong promoter holding can provide stability, the lack of institutional backing could limit the stock’s growth potential. Moreover, the company’s debt load and negative interest coverage ratio could lead to liquidity challenges if the market does not favorably shift. Investors might consider the potential for recovery in the tea and coffee sectors, but they should be wary of the operational and financial hurdles that Andrew Yule currently faces. A cautious approach would be prudent, weighing the potential for recovery against the backdrop of existing financial strains and market conditions. Overall, while there may be pockets of opportunity, the risks appear substantial, warranting careful consideration before investing.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Andrew Yule & Company Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 371 Cr. | 172 | 295/162 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 | |
| Diana Tea Company Ltd | 42.1 Cr. | 28.1 | 43.8/26.0 | 47.3 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 127 Cr. | 141 | 189/126 | 24.7 | 223 | 1.07 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 8.62 Cr. | 13.6 | 13.6/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 127 Cr. | 410 | 689/354 | 13.6 | 528 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 8,776.24 Cr | 398.88 | 69.42 | 265.00 | 0.43% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 57 | 116 | 120 | 81 | 59 | 88 | 87 | 77 | 56 | 89 | 68 | 98 | 56 |
| Expenses | 75 | 94 | 114 | 98 | 79 | 100 | 108 | 112 | 67 | 79 | 88 | 141 | 84 |
| Operating Profit | -18 | 22 | 6 | -16 | -21 | -12 | -21 | -35 | -12 | 10 | -20 | -42 | -28 |
| OPM % | -31% | 19% | 5% | -20% | -36% | -14% | -25% | -46% | -21% | 11% | -29% | -43% | -49% |
| Other Income | 3 | 11 | 9 | 9 | 10 | 8 | 12 | 9 | 5 | 11 | 10 | 37 | 60 |
| Interest | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 5 | 5 | 5 | 4 | -7 | 5 |
| Depreciation | 1 | 2 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 17 | 2 |
| Profit before tax | -18 | 29 | 10 | -12 | -16 | -9 | -15 | -33 | -13 | 15 | -15 | -15 | 26 |
| Tax % | 0% | 13% | 55% | -13% | 0% | -21% | -14% | -16% | -2% | 11% | -9% | -19% | 7% |
| Net Profit | -9 | 21 | 7 | -6 | -8 | -5 | -12 | -22 | -3 | 15 | -14 | -1 | 20 |
| EPS in Rs | -0.19 | 0.43 | 0.14 | -0.12 | -0.15 | -0.11 | -0.26 | -0.45 | -0.05 | 0.30 | -0.29 | -0.01 | 0.41 |
Last Updated: August 19, 2025, 11:45 pm
Below is a detailed analysis of the quarterly data for Andrew Yule & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 98.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 42.00 Cr..
- For Expenses, as of Jun 2025, the value is 84.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 141.00 Cr. (Mar 2025) to 84.00 Cr., marking a decrease of 57.00 Cr..
- For Operating Profit, as of Jun 2025, the value is -28.00 Cr.. The value appears strong and on an upward trend. It has increased from -42.00 Cr. (Mar 2025) to -28.00 Cr., marking an increase of 14.00 Cr..
- For OPM %, as of Jun 2025, the value is -49.00%. The value appears to be declining and may need further review. It has decreased from -43.00% (Mar 2025) to -49.00%, marking a decrease of 6.00%.
- For Other Income, as of Jun 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2025) to 60.00 Cr., marking an increase of 23.00 Cr..
- For Interest, as of Jun 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -7.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 12.00 Cr..
- For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 17.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 15.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from -15.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 41.00 Cr..
- For Tax %, as of Jun 2025, the value is 7.00%. The value appears to be increasing, which may not be favorable. It has increased from -19.00% (Mar 2025) to 7.00%, marking an increase of 26.00%.
- For Net Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from -1.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 21.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.41. The value appears strong and on an upward trend. It has increased from -0.01 (Mar 2025) to 0.41, marking an increase of 0.42.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:57 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 382 | 372 | 385 | 421 | 367 | 312 | 299 | 330 | 414 | 374 | 310 | 311 | 312 |
| Expenses | 350 | 386 | 381 | 409 | 362 | 330 | 336 | 332 | 423 | 380 | 399 | 374 | 392 |
| Operating Profit | 32 | -14 | 4 | 12 | 6 | -19 | -37 | -2 | -8 | -6 | -89 | -64 | -79 |
| OPM % | 8% | -4% | 1% | 3% | 2% | -6% | -12% | -0% | -2% | -2% | -29% | -20% | -25% |
| Other Income | 11 | 46 | 22 | 42 | 28 | 40 | 29 | 31 | 34 | 32 | 38 | 64 | 118 |
| Interest | 12 | 11 | 10 | 9 | 7 | 6 | 8 | 8 | 8 | 10 | 16 | 22 | 7 |
| Depreciation | 5 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 7 | 22 |
| Profit before tax | 26 | 14 | 10 | 38 | 20 | 7 | -23 | 14 | 11 | 9 | -74 | -29 | 10 |
| Tax % | 12% | 7% | 11% | 16% | 32% | 24% | -5% | -46% | 109% | 87% | -13% | -10% | |
| Net Profit | 35 | 46 | 21 | 45 | 22 | 6 | -22 | 35 | -5 | 13 | -47 | -3 | 20 |
| EPS in Rs | 1.08 | 1.38 | 0.63 | 0.93 | 0.46 | 0.11 | -0.44 | 0.72 | -0.11 | 0.26 | -0.97 | -0.06 | 0.41 |
| Dividend Payout % | 0% | 7% | 0% | 11% | 9% | 0% | 0% | 0% | 0% | 3% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 31.43% | -54.35% | 114.29% | -51.11% | -72.73% | -466.67% | 259.09% | -114.29% | 360.00% | -461.54% | 93.62% |
| Change in YoY Net Profit Growth (%) | 0.00% | -85.78% | 168.63% | -165.40% | -21.62% | -393.94% | 725.76% | -373.38% | 474.29% | -821.54% | 555.16% |
Andrew Yule & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 1% |
| 3 Years: | -9% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | % |
| TTM: | 147% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 14% |
| 3 Years: | 8% |
| 1 Year: | -45% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -2% |
| 3 Years: | -6% |
| Last Year: | -8% |
Last Updated: September 5, 2025, 2:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:22 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 65 | 67 | 67 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 |
| Reserves | 239 | 278 | 299 | 238 | 257 | 253 | 245 | 281 | 276 | 287 | 242 | 241 | 264 |
| Borrowings | 94 | 98 | 88 | 41 | 28 | 53 | 81 | 70 | 67 | 100 | 114 | 105 | 120 |
| Other Liabilities | 178 | 189 | 187 | 212 | 187 | 187 | 179 | 187 | 197 | 257 | 257 | 308 | 273 |
| Total Liabilities | 576 | 631 | 641 | 589 | 570 | 591 | 602 | 636 | 638 | 742 | 711 | 752 | 755 |
| Fixed Assets | 181 | 183 | 186 | 81 | 85 | 87 | 94 | 103 | 112 | 142 | 162 | 192 | 191 |
| CWIP | 6 | 5 | 1 | 18 | 37 | 59 | 77 | 75 | 82 | 94 | 88 | 61 | 63 |
| Investments | 97 | 131 | 143 | 169 | 179 | 179 | 202 | 203 | 197 | 201 | 219 | 244 | 240 |
| Other Assets | 292 | 313 | 311 | 321 | 270 | 265 | 228 | 255 | 247 | 305 | 242 | 256 | 261 |
| Total Assets | 576 | 631 | 641 | 589 | 570 | 591 | 602 | 636 | 638 | 742 | 711 | 752 | 755 |
Below is a detailed analysis of the balance sheet data for Andrew Yule & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 98.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 98.00 Cr..
- For Reserves, as of Sep 2025, the value is 264.00 Cr.. The value appears strong and on an upward trend. It has increased from 241.00 Cr. (Mar 2025) to 264.00 Cr., marking an increase of 23.00 Cr..
- For Borrowings, as of Sep 2025, the value is 120.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 105.00 Cr. (Mar 2025) to 120.00 Cr., marking an increase of 15.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 273.00 Cr.. The value appears to be improving (decreasing). It has decreased from 308.00 Cr. (Mar 2025) to 273.00 Cr., marking a decrease of 35.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 755.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 752.00 Cr. (Mar 2025) to 755.00 Cr., marking an increase of 3.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 191.00 Cr.. The value appears to be declining and may need further review. It has decreased from 192.00 Cr. (Mar 2025) to 191.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2025) to 63.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 240.00 Cr.. The value appears to be declining and may need further review. It has decreased from 244.00 Cr. (Mar 2025) to 240.00 Cr., marking a decrease of 4.00 Cr..
- For Other Assets, as of Sep 2025, the value is 261.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2025) to 261.00 Cr., marking an increase of 5.00 Cr..
- For Total Assets, as of Sep 2025, the value is 755.00 Cr.. The value appears strong and on an upward trend. It has increased from 752.00 Cr. (Mar 2025) to 755.00 Cr., marking an increase of 3.00 Cr..
Notably, the Reserves (264.00 Cr.) exceed the Borrowings (120.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -62.00 | -112.00 | -84.00 | -29.00 | -22.00 | -72.00 | -118.00 | -72.00 | -75.00 | -106.00 | -203.00 | -169.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 107 | 103 | 103 | 79 | 79 | 62 | 70 | 70 | 115 | 118 | 146 |
| Inventory Days | 131 | 104 | 132 | 106 | 156 | 203 | 201 | 185 | 193 | 155 | 109 | 134 |
| Days Payable | 301 | 250 | 281 | 223 | 212 | 227 | 223 | 252 | 231 | 304 | 246 | 351 |
| Cash Conversion Cycle | -74 | -40 | -46 | -15 | 23 | 55 | 40 | 2 | 32 | -33 | -19 | -71 |
| Working Capital Days | -25 | -41 | -27 | 16 | 1 | -26 | -87 | -54 | -10 | -53 | -154 | -187 |
| ROCE % | 10% | 6% | 4% | 7% | 7% | 2% | -4% | 5% | 9% | 4% | -14% | -7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | -0.06 | -0.97 | 0.26 | -0.11 | 0.72 |
| Diluted EPS (Rs.) | -0.06 | -0.97 | 0.26 | -0.11 | 0.72 |
| Cash EPS (Rs.) | -0.38 | -1.17 | 0.15 | 0.11 | 0.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 6.93 | 6.94 | 7.87 | 7.65 | 7.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 6.93 | 6.94 | 7.87 | 7.65 | 7.74 |
| Revenue From Operations / Share (Rs.) | 6.38 | 6.34 | 7.65 | 8.47 | 6.76 |
| PBDIT / Share (Rs.) | 0.00 | -1.04 | 0.51 | 0.98 | 0.60 |
| PBIT / Share (Rs.) | -0.13 | -1.18 | 0.38 | 0.85 | 0.46 |
| PBT / Share (Rs.) | -0.58 | -1.50 | 0.18 | 0.22 | 0.30 |
| Net Profit / Share (Rs.) | -0.52 | -1.31 | 0.02 | -0.01 | 0.41 |
| NP After MI And SOA / Share (Rs.) | -0.05 | -0.97 | 0.25 | -0.10 | 0.71 |
| PBDIT Margin (%) | 0.00 | -16.37 | 6.79 | 11.62 | 8.91 |
| PBIT Margin (%) | -2.11 | -18.62 | 5.07 | 10.06 | 6.89 |
| PBT Margin (%) | -9.14 | -23.62 | 2.39 | 2.67 | 4.44 |
| Net Profit Margin (%) | -8.19 | -20.73 | 0.31 | -0.23 | 6.18 |
| NP After MI And SOA Margin (%) | -0.91 | -15.32 | 3.38 | -1.28 | 10.63 |
| Return on Networth / Equity (%) | -0.83 | -13.99 | 3.28 | -1.42 | 9.27 |
| Return on Capital Employeed (%) | -1.69 | -14.42 | 4.18 | 9.57 | 5.42 |
| Return On Assets (%) | -0.37 | -6.68 | 1.70 | -0.83 | 5.52 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Total Debt / Equity (X) | 0.31 | 0.33 | 0.25 | 0.17 | 0.18 |
| Asset Turnover Ratio (%) | 0.42 | 0.42 | 0.63 | 0.76 | 0.62 |
| Current Ratio (X) | 0.66 | 0.70 | 0.98 | 1.11 | 1.09 |
| Quick Ratio (X) | 0.55 | 0.59 | 0.80 | 0.86 | 0.87 |
| Inventory Turnover Ratio (X) | 8.38 | 2.36 | 2.57 | 1.99 | 1.88 |
| Interest Coverage Ratio (X) | 0.00 | -3.27 | 2.54 | 6.04 | 3.64 |
| Interest Coverage Ratio (Post Tax) (X) | -0.16 | -3.11 | 1.12 | 3.72 | 3.62 |
| Enterprise Value (Cr.) | 1325.93 | 1776.01 | 1039.44 | 1022.55 | 967.67 |
| EV / Net Operating Revenue (X) | 4.25 | 5.73 | 2.78 | 2.47 | 2.93 |
| EV / EBITDA (X) | -51194.25 | -35.00 | 40.90 | 21.23 | 32.85 |
| MarketCap / Net Operating Revenue (X) | 4.04 | 5.49 | 2.64 | 2.38 | 2.92 |
| Price / BV (X) | 3.71 | 5.01 | 2.57 | 2.64 | 2.55 |
| Price / Net Operating Revenue (X) | 4.04 | 5.49 | 2.64 | 2.38 | 2.92 |
| EarningsYield | 0.00 | -0.02 | 0.01 | -0.01 | 0.03 |
After reviewing the key financial ratios for Andrew Yule & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has increased from -0.97 (Mar 24) to -0.06, marking an increase of 0.91.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has increased from -0.97 (Mar 24) to -0.06, marking an increase of 0.91.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.38. This value is below the healthy minimum of 3. It has increased from -1.17 (Mar 24) to -0.38, marking an increase of 0.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.93. It has decreased from 6.94 (Mar 24) to 6.93, marking a decrease of 0.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.93. It has decreased from 6.94 (Mar 24) to 6.93, marking a decrease of 0.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 6.38. It has increased from 6.34 (Mar 24) to 6.38, marking an increase of 0.04.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 2. It has increased from -1.04 (Mar 24) to 0.00, marking an increase of 1.04.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.13. This value is below the healthy minimum of 0. It has increased from -1.18 (Mar 24) to -0.13, marking an increase of 1.05.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.58. This value is below the healthy minimum of 0. It has increased from -1.50 (Mar 24) to -0.58, marking an increase of 0.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 2. It has increased from -1.31 (Mar 24) to -0.52, marking an increase of 0.79.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.05. This value is below the healthy minimum of 2. It has increased from -0.97 (Mar 24) to -0.05, marking an increase of 0.92.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -16.37 (Mar 24) to 0.00, marking an increase of 16.37.
- For PBIT Margin (%), as of Mar 25, the value is -2.11. This value is below the healthy minimum of 10. It has increased from -18.62 (Mar 24) to -2.11, marking an increase of 16.51.
- For PBT Margin (%), as of Mar 25, the value is -9.14. This value is below the healthy minimum of 10. It has increased from -23.62 (Mar 24) to -9.14, marking an increase of 14.48.
- For Net Profit Margin (%), as of Mar 25, the value is -8.19. This value is below the healthy minimum of 5. It has increased from -20.73 (Mar 24) to -8.19, marking an increase of 12.54.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.91. This value is below the healthy minimum of 8. It has increased from -15.32 (Mar 24) to -0.91, marking an increase of 14.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is -0.83. This value is below the healthy minimum of 15. It has increased from -13.99 (Mar 24) to -0.83, marking an increase of 13.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is -1.69. This value is below the healthy minimum of 10. It has increased from -14.42 (Mar 24) to -1.69, marking an increase of 12.73.
- For Return On Assets (%), as of Mar 25, the value is -0.37. This value is below the healthy minimum of 5. It has increased from -6.68 (Mar 24) to -0.37, marking an increase of 6.31.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.31. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.31, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. There is no change compared to the previous period (Mar 24) which recorded 0.42.
- For Current Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1.5. It has decreased from 0.70 (Mar 24) to 0.66, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.59 (Mar 24) to 0.55, marking a decrease of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.38. This value exceeds the healthy maximum of 8. It has increased from 2.36 (Mar 24) to 8.38, marking an increase of 6.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. It has increased from -3.27 (Mar 24) to 0.00, marking an increase of 3.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.16. This value is below the healthy minimum of 3. It has increased from -3.11 (Mar 24) to -0.16, marking an increase of 2.95.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,325.93. It has decreased from 1,776.01 (Mar 24) to 1,325.93, marking a decrease of 450.08.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.25. This value exceeds the healthy maximum of 3. It has decreased from 5.73 (Mar 24) to 4.25, marking a decrease of 1.48.
- For EV / EBITDA (X), as of Mar 25, the value is -51,194.25. This value is below the healthy minimum of 5. It has decreased from -35.00 (Mar 24) to -51,194.25, marking a decrease of 51,159.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.04. This value exceeds the healthy maximum of 3. It has decreased from 5.49 (Mar 24) to 4.04, marking a decrease of 1.45.
- For Price / BV (X), as of Mar 25, the value is 3.71. This value exceeds the healthy maximum of 3. It has decreased from 5.01 (Mar 24) to 3.71, marking a decrease of 1.30.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.04. This value exceeds the healthy maximum of 3. It has decreased from 5.49 (Mar 24) to 4.04, marking a decrease of 1.45.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.02 (Mar 24) to 0.00, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Andrew Yule & Company Ltd:
- Net Profit Margin: -8.19%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -1.69% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.83% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.16
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.55
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 233 (Industry average Stock P/E: 69.42)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.31
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -8.19%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | Yule House, Kolkata West Bengal 700001 | com.sec@andrewyule.com http://www.andrewyule.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ananta Mohan Singh | Chairman & Managing Director |
| Mr. Sanjay Verma | Director - Finance |
| Mr. Sunder Pal Singh | Ind. Non-Executive Director |
| Ms. Swapna Tripathy | Ind. Non-Executive Director |
| Mr. Vijay Mittal | Nominee Director |
| Mr. Brajesh Kumar Srivastava | Nominee Director |
FAQ
What is the intrinsic value of Andrew Yule & Company Ltd?
Andrew Yule & Company Ltd's intrinsic value (as of 11 December 2025) is 111.84 which is 384.16% higher the current market price of 23.10, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 1,128 Cr. market cap, FY2025-2026 high/low of 43.0/22.0, reserves of ₹264 Cr, and liabilities of 755 Cr.
What is the Market Cap of Andrew Yule & Company Ltd?
The Market Cap of Andrew Yule & Company Ltd is 1,128 Cr..
What is the current Stock Price of Andrew Yule & Company Ltd as on 11 December 2025?
The current stock price of Andrew Yule & Company Ltd as on 11 December 2025 is 23.1.
What is the High / Low of Andrew Yule & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Andrew Yule & Company Ltd stocks is 43.0/22.0.
What is the Stock P/E of Andrew Yule & Company Ltd?
The Stock P/E of Andrew Yule & Company Ltd is 233.
What is the Book Value of Andrew Yule & Company Ltd?
The Book Value of Andrew Yule & Company Ltd is 7.39.
What is the Dividend Yield of Andrew Yule & Company Ltd?
The Dividend Yield of Andrew Yule & Company Ltd is 0.00 %.
What is the ROCE of Andrew Yule & Company Ltd?
The ROCE of Andrew Yule & Company Ltd is 6.83 %.
What is the ROE of Andrew Yule & Company Ltd?
The ROE of Andrew Yule & Company Ltd is 7.96 %.
What is the Face Value of Andrew Yule & Company Ltd?
The Face Value of Andrew Yule & Company Ltd is 2.00.